Clinical Trial: Darzalex (daratumamab) with Revlimid/Velcade/Dex for Newly Diagnosed Myeloma

Peter Voorhees, MD of the Levine Cancer Institute shares a clinical trial for newly diagnosed myeloma patients using Darzalex (daratumumab), Revlimid, Velcade and dexamethasone before transplant, then adding dara into consolidation and maintenance post transplant. For more clinical trials, go to www.healthtree...

[@JetLag52]

Just celebrated the first anniversary under RVD + Daratumumab therapy. 4 cycles followed by mobilisation & transplant; After 3 months of recovery I went through 2 more cycles and now I started a 2 years long therapy of montly subcutaneous Daratumumab. Results seem to be hopeful and I admit I had almost no adverse events along this one-year journey. I feel good !

[@jennyahlstrom23]

Good to hear Vincent!

[@vickyrodden5273]

Hello, Dr. Voorhees How long before we see improvement for Myeloma when taking Darzalex? This is my husbands third week. Thank you